Literature DB >> 19145403

Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis.

Dragan Lepur1, Vjerislav Peterković, Nevija Kalabrić-Lepur.   

Abstract

Neuromyelitis optica (NMO) is a rare inflammatory demyelinating disease of the central nervous system that causes severe attacks of optic neuritis and myelitis. Abnormal CSF findings are one of the characteristics of NMO that help to distinguish it from classical multiple sclerosis. Here we describe two cases of Devic's syndrome with CSF findings suggestive of bacterial meningomyelitis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19145403     DOI： 10.1007/s10072-008-0002-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.830


  8 in total

1.  The clinical course of neuromyelitis optica (Devic's syndrome).

Authors:  D M Wingerchuk; W F Hogancamp; P C O'Brien; B G Weinshenker
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Neuromyelitis optica.

Authors:  D M Wingerchuk
Journal:  Int MS J       Date:  2006-05

3.  Cerebrospinal fluid findings in Devic's neuromyelitis optica.

Authors:  M Zaffaroni
Journal:  Neurol Sci       Date:  2004-11       Impact factor: 3.307

4.  Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.

Authors:  J I O'Riordan; H L Gallagher; A J Thompson; R S Howard; D P Kingsley; E J Thompson; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

6.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

7.  Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

Authors:  Angelo Ghezzi; Roberto Bergamaschi; Vittorio Martinelli; Maria Trojano; M Rosaria Tola; Elisa Merelli; Luigi Mancardi; Paolo Gallo; Massimo Filippi; Mauro Zaffaroni; Giancarlo Comi
Journal:  J Neurol       Date:  2004-01       Impact factor: 4.849

8.  Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse.

Authors:  E Milano; A Di Sapio; S Malucchi; M Capobianco; R Bottero; A Sala; F Gilli; A Bertolotto
Journal:  Neurol Sci       Date:  2003-10       Impact factor: 3.307
  8 in total
  6 in total

1.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

2.  The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation.

Authors:  S Jarius; B Wildemann
Journal:  J Neurol       Date:  2012-01-12       Impact factor: 4.849

Review 3.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Authors:  Sven Jarius; Ingo Kleiter; Klemens Ruprecht; Nasrin Asgari; Kalliopi Pitarokoili; Nadja Borisow; Martin W Hümmert; Corinna Trebst; Florence Pache; Alexander Winkelmann; Lena-Alexandra Beume; Marius Ringelstein; Oliver Stich; Orhan Aktas; Mirjam Korporal-Kuhnke; Alexander Schwarz; Carsten Lukas; Jürgen Haas; Kai Fechner; Mathias Buttmann; Judith Bellmann-Strobl; Hanna Zimmermann; Alexander U Brandt; Diego Franciotta; Kathrin Schanda; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-11-01       Impact factor: 8.322

Review 5.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

6.  MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report.

Authors:  Jordi Kühne Escolà; Cornelius Deuschl; Andreas Junker; Fabian Dusse; Refik Pul; Christoph Kleinschnitz; Martin Köhrmann; Benedikt Frank
Journal:  Ther Adv Neurol Disord       Date:  2022-01-19       Impact factor: 6.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.